• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMMG
Immage Biotherapeutics Corp
150.0
0.0x
---
United StatesPLTYF
Plastec Technologies Ltd
258.8K
-54.1x
---
United StatesHWIN
Makamer Holdings Inc
40.0
0.0x
---
United StatesEUOT
Eurotech Ltd
4.4K
0.0x
---
United StatesSINC
Sincerity Applied Materials Holdings Corp
50.1K
-0.3x
---
United StatesPTOI
Plastic2Oil Inc
187.1K
-0.1x
---
As of 2024-11-22

Company Information

Immage Biotherapeutics Corp. is a biotechnology company. The Company is engaged in developing cancer immunotherapy through development of cutting-edge immunotherapy candidates using bioinformatics and outsourced laboratory resources. It is focused on developing immunotherapy biologics to treat various cancers. The Company develops, markets and licenses its immunotherapy candidate for melanoma-associated antigen-A (MAGE A). The Company plans to focus on the development of immunotherapy for breast and prostate cancer. The Company focuses on developing a fusion/hybrid antigen cancer vaccine that would not only be human leukocyte antigen (HLA) free, but also be effective to all the isomers associated with MAGE A, from 1 to 11, and the identification and development of immunotherapy candidates from its intellectual property library for the preparation for human clinical trials using a viral vector construct.

Contact Information

Headquarters
10411 Motor City Dr Ste 750BETHESDA, MD, United States 20817-1289
Phone
443-961-1185
Fax
---

Executives

Chairman of the Board, Chief Scientific Officer
Anton Dormer
President, Chief Executive Officer, Treasurer, Secretary, Director
Zhi Cong Mou
Chief Financial Officer, Director
Elton Norman
Chief Operating Officer, Director
Mahesh Narayanan
Vice President - Bioformatics
Daniel Achinko

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$150.00
Revenue (TTM)
$0.00
Shares Outstanding
151.7M
Immage Biotherapeutics Corp does not pay a dividend.
Beta
---
EPS
$-0.01
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.